| Firm | Analyst | Contact Information |
|---|---|---|
| Bank of America One Bryant Park New York, NY 10036 |
Derik de Bruin | Email: derik.de_bruin@bofa.com Phone: (646) 855-3100 |
| BTIG, LLC 260 Franklin Street, Suite 720 Boston, MA 02110 |
Mark Massaro | Email: mmassaro@btig.com Phone: (781) 258-5702 |
| Craig-Hallum Capital Group, LLC 222 South Ninth Street Suite 350 Minneapolis, MN 55402 |
Alexander Nowak, CFA | Email: Alex.Nowak@craig-hallum.com Phone: (612) 334-6347 |
| Goldman, Sachs & Co 200 West Street New York, NY 10282 |
Matt Sykes | Email: matthew.c.sykes@gs.com Phone: (212) 902-3668 |
| Guggenheim Securities, LLC 222 Berkeley St. #1104 Boston, MA 02116 |
David Westenberg, CFA | Email: david.westenburg@guggenheimpartners.com Phone: (617) 859-4624 |
| Morgan Stanley 1585 Broadway, 34th Floor New York, NY 10036 |
Tejas Savant | Email: tejas.savant@morganstanley.com Phone: (212) 761-1955 |
| Needham & Company One Federal Street Boston, MA 02110 |
Mike Matson, CFA | Email: mmatson@needhamco.com Phone: (617) 457-0949 |
| Raymond James 880 Carillon Parkway Saint Petersburg, FL 33716 |
Andrew Cooper | Email: andrew.cooper@raymondjames.com Phone: (727) 567-2295 |
| Stephens, Inc. 111 Center Street Little Rock, AR 72201 |
Jacob Johnson, CFA | Email: Jacob.Johnson@stephens.com Phone: (615) 279-4355 |
| SVB Leerink LLC One Federal Street, 37th Floor Boston, MA 02110 |
Puneet Souda | Email: puneet.souda@svbleerink.com Phone: (212) 277-6091 |
| The Benchmark Company 150 E 58th Street, 17th Floor New York, NY 10155 |
Bruce Jackson | Email: bjackson@benchmarkcompany.com Phone: (651) 315-2260 |
| William Blair & Company, LLC 150 N. Riverside Chicago, IL 60606 |
Brian Weinstein, CFA | Email: bweinstein@williamblair.com Phone: (312) 364-8170 |
NeoGenomics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding NeoGenomics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of NeoGenomics, Inc. or its management. NeoGenomics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.